The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development.
Loading...
Embargo End Date
ICR Authors
Authors
Kerkmeijer, LGW
Fuller, CD
Verkooijen, HM
Verheij, M
Choudhury, A
Harrington, KJ
Schultz, C
Sahgal, A
Frank, SJ
Goldwein, J
Brown, KJ
Minsky, BD
van Vulpen, M
MR-Linac Consortium Clinical Steering Committee,
Fuller, CD
Verkooijen, HM
Verheij, M
Choudhury, A
Harrington, KJ
Schultz, C
Sahgal, A
Frank, SJ
Goldwein, J
Brown, KJ
Minsky, BD
van Vulpen, M
MR-Linac Consortium Clinical Steering Committee,
Document Type
Journal Article
Date
2016-10-13
Date Accepted
2016-09-28
Abstract
An international research consortium has been formed to facilitate evidence-based introduction of MR-guided radiotherapy (MR-linac) and to address how the MR-linac could be used to achieve an optimized radiation treatment approach to improve patients' survival, local, and regional tumor control and quality of life. The present paper describes the organizational structure of the clinical part of the MR-linac consortium. Furthermore, it elucidates why collaboration on this large project is necessary, and how a central data registry program will be implemented.
Citation
Frontiers in oncology, 2016, 6 pp. 215 - ?
Source Title
Publisher
FRONTIERS MEDIA SA
ISSN
2234-943X
eISSN
2234-943X
Research Team
Targeted Therapy